HealthEquity (HQY)
(Delayed Data from NSDQ)
$80.98 USD
+1.22 (1.53%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $80.98 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HQY 80.98 +1.22(1.53%)
Will HQY be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for HQY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HQY
3 Reasons Why You Should Hold HealthEquity (HQY) Stock Now
Here's Why HealthEquity (HQY) is a Strong Growth Stock
HQY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why HealthEquity (HQY) is a Strong Growth Stock
Here's Why You Should Retain HealthEquity (HQY) Stock for Now
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Other News for HQY
First Week of March 2025 Options Trading For HealthEquity (HQY)
$100 Invested In HealthEquity 10 Years Ago Would Be Worth This Much Today
Webster Financial: Diversity Of Deposits A Hidden Asset
Rewey Asset Management Q2 2024 Investment Letter
Analysts Conflicted on These Healthcare Names: Healthequity (HQY) and Embecta Corporation (EMBC)